FDA approves IDE for Medtronic Prevail drug-coated balloon
October 23, 2024
Medtronic (NYSE: MDT)+
announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated balloon (DCB).
Medtronic (NYSE: MDT)+
announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated balloon (DCB).
A potentially cost-saving UK digital health innovation that is awaiting NHS England funding, more than two years after NICE recommended its national adoption in the NHS, will soon be made available to patients in the US after it secured FDA clearance.
Leica Microsystems has announced the release of SpectraPlex, a 3D high-multiplex solution for spatial discoveries on the STELLARIS confocal platform. The company claims that this innovation sets a new benchmark for 3D spatial phenotyping in life science research.
Asahi Kasei Medical has launched the Planova FG1, a ‘next-generation’ virus removal filter featuring higher flux for the manufacture of biotherapeutics.
Gentuity announced today that it received FDA 510(k) clearance for its HF-OCT imaging system with the Vis-Rx micro-imaging catheter.
Peytant Solutions announced today that the FDA granted marketing authorization for its AMStent tracheobronchial covered stent system.
Siemens Healthineers says a new FDA clearance will advance the care of people at risk of heart attacks in the United States.
Mucocort AB has been granted a patent in China for its innovative product/technology, which has previously been approved under the European Patent System (EPC).
Mira has launched Mira Hormone Monitor: Menopause Transitions Kit to help women aged 35 and older track their hormones to spot early signs of perimenopause and manage them effectively.
MobilePoser makes motion capture more accessible by using sensors your devices already have